Ameritas Investment Partners, Inc. Chinook Therapeutics, Inc. Transaction History

Ameritas Investment Partners, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$18.66 - $38.58 $16,420 - $33,950	880 Added 22.51%	4,790 $184,000
Q3 2022 Nov 14, 2022	BUY	$17.51 - $23.37 $15,583 - $20,799	890 Added 29.47%	3,910 $76,000
Q4 2021 Feb 11, 2022	BUY	$10.69 - $16.83 $5,922 - $9,323	554 Added 22.47%	3,020 $49,000
Q2 2021 Aug 06, 2021	BUY	$13.6 - $18.98 $18,455 - $25,755	1,357 Added 122.36%	2,466 $35,000
Q4 2020 Feb 12, 2021	BUY	$11.9 - $20.91 $13,197 - $23,189	1,109 New	1,109 $18,000

234K

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.